Martin & CO Inc Bio Rad Laboratories, Inc. Transaction History

Martin & CO Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	BUY	$320.01 - $409.07 $65,602 - $83,859	205 Added 3.53%	6,012 $2.11 Million
Q4 2019 Feb 13, 2020	BUY	$319.73 - $374.2 $22,381 - $26,194	70 Added 1.22%	5,807 $2.15 Million
Q3 2019 Nov 14, 2019	BUY	$304.55 - $345.24 $23,450 - $26,583	77 Added 1.36%	5,737 $1.91 Million
Q2 2019 Aug 15, 2019	BUY	$286.93 - $312.59 $10,042 - $10,940	35 Added 0.62%	5,660 $1.77 Million
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $53,832 - $76,178	240 Added 4.46%	5,625 $1.72 Million
Q4 2018 Feb 13, 2019	SELL	$220.1 - $309.0 $1,100 - $1,545	-5 Reduced 0.09%	5,385 $1.25 Million
Q3 2018 Nov 15, 2018	SELL	$289.28 - $326.15 $7,231 - $8,153	-25 Reduced 0.46%	5,390 $1.69 Million
Q2 2018 Aug 15, 2018	BUY	$244.1 - $303.88 $4,882 - $6,077	20 Added 0.37%	5,415 $1.56 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $114,645 - $134,313	-490 Reduced 8.33%	5,395 $1.35 Million
Q3 2017 Nov 15, 2017	SELL	$212.27 - $242.28 $199,533 - $227,743	-940 Reduced 13.77%	5,885 $1.31 Million
Q2 2017 Aug 15, 2017	BUY	N/A	6,825	6,825 $1.55 Million

479

19.2M

15.7K

11.5K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.53B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Martin & CO Inc , based on Form 13F filings with the SEC.

Stay updated on Martin & CO Inc with notifications on news.